Free Trial

Cardinal Health (CAH) Stock Price, News & Analysis

+0.34 (+0.35%)
(As of 05/24/2024 07:00 PM ET)
Today's Range
50-Day Range
52-Week Range
1.21 million shs
Average Volume
2.21 million shs
Market Capitalization
$23.48 billion
P/E Ratio
Dividend Yield
Price Target

Cardinal Health MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.50 Rating Score
11.6% Upside
$107.57 Price Target
Short Interest
3.51% of Float Sold Short
Dividend Strength
Based on Four Factors
Upright™ Environmental Score
News Sentiment
0.69mentions of Cardinal Health in the last 14 days
Based on 20 Articles This Week
Insider Trading
Proj. Earnings Growth
From $7.35 to $7.55 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.49 out of 5 stars

Medical Sector

93rd out of 921 stocks

Drugs, Proprietaries, & Sundries Industry

3rd out of 6 stocks

CAH stock logo

About Cardinal Health Stock (NYSE:CAH)

Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

CAH Stock Price History

CAH Stock News Headlines

For Cardinal Health, the Proof Will be in Its Performance
Investors are familiar with the phrase "buy the rumor, sell the news." However, Cardinal Health Inc. NYSE: CAH proved that investors can buy and sell the news.
For Cardinal Health, the Proof Will be in Its Performance
CAH stock is up after mixed earnings that investors hope is enough to hold support after the company announced its contract for OptumRx will expire in June
Cardinal Health's Valuation Makes The Name Unattractive
Cardinal Health Inc Q3 Profit Decreases, but beats estimates
See More Headlines
Receive CAH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cardinal Health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 4/15 Dividend
Dividend Payable
Last Earnings
Fiscal Year End
Ex-Dividend for 7/15 Dividend
Dividend Payable
Next Earnings (Estimated)

Industry, Sector and Symbol

Drugs, proprietaries, & sundries
Health Care Distributors
Year Founded

Price Target and Rating

Average Stock Price Target
High Stock Price Target
Low Stock Price Target
Potential Upside/Downside
Consensus Rating
Moderate Buy
Rating Score (0-4)
Research Coverage
12 Analysts


Net Income
$261 million
Pretax Margin


Sales & Book Value

Annual Sales
$205.01 billion
Cash Flow
$8.68 per share
Book Value
($13.39) per share


Free Float
Market Cap
$23.48 billion

Social Links

7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

CAH Stock Analysis - Frequently Asked Questions

Should I buy or sell Cardinal Health stock right now?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cardinal Health in the last year. There are currently 1 sell rating, 4 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" CAH shares.
View CAH analyst ratings
or view top-rated stocks.

What is Cardinal Health's stock price target for 2024?

12 analysts have issued 1-year price targets for Cardinal Health's stock. Their CAH share price targets range from $90.00 to $128.00. On average, they anticipate the company's stock price to reach $107.57 in the next twelve months. This suggests a possible upside of 11.6% from the stock's current price.
View analysts price targets for CAH
or view top-rated stocks among Wall Street analysts.

How have CAH shares performed in 2024?

Cardinal Health's stock was trading at $100.80 at the beginning of the year. Since then, CAH stock has decreased by 4.4% and is now trading at $96.39.
View the best growth stocks for 2024 here

When is Cardinal Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 20th 2024.
View our CAH earnings forecast

How were Cardinal Health's earnings last quarter?

Cardinal Health, Inc. (NYSE:CAH) issued its earnings results on Thursday, May, 2nd. The company reported $2.08 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.95 by $0.13. The company earned $54.90 billion during the quarter, compared to the consensus estimate of $56.05 billion. Cardinal Health had a negative trailing twelve-month return on equity of 54.74% and a net margin of 0.25%. The firm's revenue was up 8.7% on a year-over-year basis. During the same period in the prior year, the business earned $1.74 earnings per share.
Read the conference call transcript

How often does Cardinal Health pay dividends? What is the dividend yield for Cardinal Health?

Cardinal Health announced a quarterly dividend on Tuesday, May 7th. Stockholders of record on Monday, July 1st will be paid a dividend of $0.5056 per share on Monday, July 15th. This represents a $2.02 dividend on an annualized basis and a yield of 2.10%. The ex-dividend date is Monday, July 1st. This is a positive change from the stock's previous quarterly dividend of $0.50.
Read our dividend analysis for CAH

Is Cardinal Health a good dividend stock?

Cardinal Health (NYSE:CAH) pays an annual dividend of $2.00 per share and currently has a dividend yield of 2.08%. The company has been increasing its dividend for 27 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 88.89%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, CAH will have a dividend payout ratio of 26.49% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CAH.

What guidance has Cardinal Health issued on next quarter's earnings?

Cardinal Health issued an update on its FY 2025 earnings guidance on Friday, May, 3rd. The company provided earnings per share guidance of 7.500- for the period, compared to the consensus EPS estimate of 7.870. The company issued revenue guidance of -.

What is Mike Kaufmann's approval rating as Cardinal Health's CEO?

357 employees have rated Cardinal Health Chief Executive Officer Mike Kaufmann on Mike Kaufmann has an approval rating of 85% among the company's employees.

What other stocks do shareholders of Cardinal Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cardinal Health investors own include AbbVie (ABBV), AT&T (T), Johnson & Johnson (JNJ), CVS Health (CVS), Exxon Mobil (XOM), Pfizer (PFE), Chevron (CVX), Intel (INTC), Cisco Systems (CSCO) and PepsiCo (PEP).

Who are Cardinal Health's major shareholders?

Cardinal Health's stock is owned by many different institutional and retail investors. Top institutional investors include Vanguard Group Inc. (12.57%), Acadian Asset Management LLC (1.53%), Price T Rowe Associates Inc. MD (1.12%), LSV Asset Management (0.99%), Bank of New York Mellon Corp (0.73%) and ProShare Advisors LLC (0.69%). Insiders that own company stock include Deborah Weitzman, Jessica L Mayer, Mary C Scherer, Michelle Brennan, Ola M Snow and Stephen M Mason.
View institutional ownership trends

How do I buy shares of Cardinal Health?

Shares of CAH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Cardinal Health have any subsidiaries?
The following companies are subsidiares of Cardinal Health: A+ Secure Packaging LLC, Access Closure, Aero-Med LLC, Alaris Medical Systems, Allegiance Corporation, Allegiance Healthcare, AssuraMed, Automatic Liquid Packaging, Bergen Brunswig Corp, Bindley Western Industries, Blue Robin LLC, Boron LePore & Associates, Borschow Hospital & Medical Supplies, Cardinal Health 100 LLC, Cardinal Health 104 LP, Cardinal Health 105 LLC, Cardinal Health 107 LLC, Cardinal Health 108 LLC, Cardinal Health 110 LLC, Cardinal Health 112 LLC, Cardinal Health 113 LLC, Cardinal Health 114 Inc., Cardinal Health 115 LLC, Cardinal Health 116 LLC, Cardinal Health 118 LLC, Cardinal Health 119 LLC, Cardinal Health 121 LLC, Cardinal Health 122 LLC, Cardinal Health 123 LLC, Cardinal Health 124 LLC, Cardinal Health 126 LLC, Cardinal Health 127 Inc., Cardinal Health 132 LLC, Cardinal Health 2 LLC, Cardinal Health 200 LLC, Cardinal Health 201 LLC, Cardinal Health 222 (Thailand) Ltd., Cardinal Health 247 Inc., Cardinal Health 249 LLC, Cardinal Health 3 LLC, Cardinal Health 414 LLC, Cardinal Health 5 LLC, Cardinal Health 6 Inc., Cardinal Health 7 LLC, Cardinal Health Australia 503 Pty. Ltd., Cardinal Health Austria 504 GmbH, Cardinal Health Belgium 505 BVBA, Cardinal Health Canada Holdings Cooperative U.A., Cardinal Health Canada Inc., Cardinal Health Chile Limitada, Cardinal Health Colombia S.A.S., Cardinal Health D.R. 203 II Ltd., Cardinal Health Denmark ApS, Cardinal Health Finland Oy, Cardinal Health Foundation, Cardinal Health France 506 SAS, Cardinal Health Funding LLC, Cardinal Health Germany 507 GmbH, Cardinal Health Germany Manufacturing GmbH, Cardinal Health IPS LLC, Cardinal Health International India Private Limited, Cardinal Health International Philippines Inc., Cardinal Health Ireland 419 Designated Activity Company, Cardinal Health Ireland 508 Limited, Cardinal Health Ireland Unlimited Company, Cardinal Health Italy 509 Srl, Cardinal Health Japan G.K., Cardinal Health K.K., Cardinal Health Korea Limited, Cardinal Health Malaysia 211 Sdn. Bhd., Cardinal Health Malta 212 Limited, Cardinal Health Managed Care Services LLC, Cardinal Health Medical Equipment Consulting (Shanghai) Co. Ltd., Cardinal Health Mexico 514 S. de R.L. de C.V., Cardinal Health Middle East FZ-LLC, Cardinal Health Netherlands 502 B.V., Cardinal Health P.R. 120 Inc., Cardinal Health P.R. 218 Inc., Cardinal Health P.R. 220 LLC, Cardinal Health Pharmaceutical Contracting LLC, Cardinal Health Pharmacy Services LLC, Cardinal Health Singapore 225 Pte. Ltd., Cardinal Health Spain 511 S.L., Cardinal Health Sweden 512 A.B., Cardinal Health Switzerland 515 GmbH, Cardinal Health Systems Inc., Cardinal Health Technologies LLC, Cardinal Health Technologies Switzerland GmbH, Cardinal Health U.K. 432 Limited, Cardinal Health do Brasil Ltd., CareFusion, Cirpro de Delicias S.A. de C.V., Convertors de Mexico S.A. de C.V., Cordis, Cordis (Shanghai) Medical Devices Co. Ltd., Cordis Corporation, Cornerstone Rheumatology L.P., Covidien Manufacturing Solutions S.A., Denver Biomedical, Dik Drug, EPIC Insurance Company, Emerge Medical, Enturia, Especialidades Medicas Kenmex S.A. de C.V., Futuremed Health Care Products, Gala Biotech, Geodax Technology, GetOutcomes LLC, Griffin Capital LLC, HLS Freight Services, Healthcare Solutions Holding, Innovative Therapies LLC, Instant Diagnostic Systems Inc., KPR Australia Pty. Ltd., KPR U.S. LLC, Kendall-Gammatron Limited, Kinray, Leader Drugstores Inc., Ludlow Technical Products Canada Ltd., MCD, Magellan Laboratories, Marin Apothecaries, MedMined, Medicine Shoppe International Inc., Medicine Shoppe International Inc., Mediquip Sdn. Bhd., Mirixa Corporation, Mirixa Corporation, MosaicGPO LLC, Mscripts, NaviHealth, One Cloverleaf LLC, Outcomes Incorporated, Outcomes Incorporated, Owen Healthcare, PCI Pharma Services, ParMed Pharmaceuticals, Patient Recovery Business of Medtronic, Pinnacle Intellectual Property Services Inc., Pinnacle Intellectual Property Services-International Inc., Pyxis Corporation, Quiroproductos de Cuauhtemoc S. de R.L. de C.V., R.P. Scherer Corporation, RGH Enterprises LLC, RainTree GPO LLC, RainTree Oncology Services, Renal Purchasing Group LLC, Rxealtime Inc., Sonexus Health LLC, Syncor International, TelePharm, TelePharm LLC, The Harvard Drug Group, The Harvard Drug Group L.L.C., Traverse GPO LLC, Viasys Healthcare, WaveMark Inc., Zuellig Pharma China, and mscripts LLC.
Read More
This page (NYSE:CAH) was last updated on 5/27/2024 by Staff

From Our Partners